Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127221) titled 'Patient-Reported Outcome Evaluation of Golimumab in the Treatment of Ankylosing Spondylitis: A Prospective Observational Study' on June 26.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
Condition:
ankylosing spondylitis
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2021-04-16
Target Sample Size: Observation group:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=298304
Published by HT Digital Content Services with permission...